[Research Progress of Sudden Cardiac Death in Forensic Medicine]

D Zheng1, K Yin1, J J Zheng1

  • 1Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.

Fa Yi Xue Za Zhi
|December 25, 2017
PubMed

Insights

Sudden cardiac death (SCD) is a leading cause of sudden death (SD). This review covers SCD research progress in forensic medicine, aiding cause of death determination and prevention strategies.

Area of Science:

  • Forensic Medicine
  • Pathology
  • Cardiology

Background:

  • Sudden death (SD) poses a significant threat to public health.
  • Sudden cardiac death (SCD) is the most common form of SD.
  • Forensic pathology research is crucial for understanding and managing SCD.

Purpose of the Study:

  • To review research progress on sudden cardiac death (SCD) in forensic medicine.
  • To provide a reference for morphological identification and cause of death determination in SCD cases.
  • To inform integrated control strategies for sudden death.

Main Methods:

  • Review of epidemiological data on SCD.
  • Analysis of morphological findings in SCD.
  • Examination of molecular pathology in SCD.
  • Exploration of virtual anatomy applications in SCD research.

Main Results:

  • Comprehensive overview of SCD research across multiple disciplines.
  • Highlights advancements in identifying SCD causes.
  • Discusses the role of technology like virtual anatomy.

Conclusions:

  • Forensic medicine plays a vital role in SCD investigation.
  • Continued research is needed for better understanding and prevention of SCD.
  • Integrated approaches are essential for managing sudden death.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K